IV-275
IV-275 is a dual BRG1/BRM bromodomain inhibitor that enhances the DNA damage and apoptotic effects of Temozolomide and Bleomycin in glioblastoma (GBM) models. It also reduces GBM cell invasiveness, making it a useful compound for studying chromatin regulation in oncology research, both in vitro and in vivo.
Product Specifications
Field of Research
Epigenetics & Chromatin
Molecular Formula
C19H18F2N2O3
Molecular Weight
360.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1818507 1.0 µg DNA
RGS19 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details